Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation

Hepatitis C recurrence continues to present a major challenge in liver transplantation (LT). Approximately 10% of hepatitis C virus (HCV)-positive recipients will develop fibrosing cholestatic hepatitis (FCH) after LT. FCH is clinically characterized as marked jaundice with cholestatic hepatic dysfu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hori, Tomohide, Onishi, Yasuharu, Kamei, Hideya, Kurata, Nobuhiko, Ishigami, Masatoshi, Ishizu, Yoji, Ogura, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049551/
https://www.ncbi.nlm.nih.gov/pubmed/27708510
http://dx.doi.org/10.20524/aog.2016.0069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049551/
https://www.ncbi.nlm.nih.gov/pubmed/27708510
http://dx.doi.org/10.20524/aog.2016.0069

Ejemplares similares